Selection Bioscience LLC
Shanghai, CN· latest recorded location
SELECTION BIOSCIENCE LLC is named on 3 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 4
- Inventors
- 9
- Granted in 2026 so far
- 0
- Most recent grant
- 18 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 3 |
| 2021 | 2 | 1 |
| 2022 | 1 | 0 |
By publication year.
Technology areas
Share of 7 documents
- A61KMedicines and medical preparations5
- A61PTherapeutic uses of medicines5
- C07DHeterocyclic compounds5
- B82YSpecific uses or applications of nanostructures2
- C07BGeneral methods of organic chemistry2
- C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen2
- C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2
- Y02PLow-carbon manufacturing2
Recent patents
- Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system18 Jan 2022US 11,225,551 B2
- Intermediate of eribulin and preparation method therefor30 Nov 2021US 11,186,570 B2
- Poly(ADP-ribose) polymerase inhibitor, preparation method and use27 Jul 2021US 11,072,596 B2
- Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system18 Feb 2021US 2021/0047467 A1
- Poly(adp-ribose) polymerase inhibitor, preparation method and use2 Jul 2020US 2020/0207736 A1
- Compound with kinase inhibitory activity and preparation method and use thereof21 May 2020US 2020/0155550 A1
- Intermediate of eribulin and preparation method therefor26 Mar 2020US 2020/0095235 A1
Most cited
By later US patents